Kidney-secreted erythropoietin lowers lipidemia via activating JAK2-STAT5 signaling in adipose tissue

BACKGROUND: Dyslipidemia is commonly observed in various kidney diseases, renal specific secreted erythropoietin (EPO) may participate in this process. However, how this process is regulated remains elusive. METHOD: Dyslipidemia was evaluated in chronic kidney disease and ischemia kidney injury anim...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinxiang, Yang, Minliang, Yu, Zhuo, Tian, Jianwei, Du, Songlin, Ding, Hanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921330/
https://www.ncbi.nlm.nih.gov/pubmed/31740386
http://dx.doi.org/10.1016/j.ebiom.2019.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921330/
https://www.ncbi.nlm.nih.gov/pubmed/31740386
http://dx.doi.org/10.1016/j.ebiom.2019.11.007

Ejemplares similares